ANMOL RANGOOLA: Open Payments
NPI 1700320025 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,711 in 92 payments from 17 companies in 2025. Trend: 2023 $1,636 · 2024 $3,501 · 2025 $19,711
Speaker / faculty: $13,965Travel & lodging: $3,425Food & beverage: $2,321
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 37 | $12,746 |
| Janssen Biotech, Inc. | 17 | $5,680 |
| Novartis Pharmaceuticals Corporation | 9 | $220 |
| UROGEN PHARMA, INC. | 2 | $197 |
| Dendreon Pharmaceuticals LLC | 3 | $166 |
| Merck Sharp & Dohme LLC | 7 | $146 |
| Aveo Pharmaceuticals, Inc. | 2 | $138 |
| Caris MPI, Inc. | 4 | $108 |
| ABBVIE INC. | 2 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
Products named: PADCEV, RYBREVANT, ERLEADA, PLUVICTO, PROVENGE, ZUSDURI, KEYTRUDA, FOTIVDA.
Industry payments across CA — which companies pay providers there.
